914639-05-7 Usage
General Description
4-Pyridinecarboxylic acid, 2-(bromomethyl)-, methyl ester, also known as 2-(Bromomethyl)nicotinic acid methyl ester, is a chemical compound used in various organic synthesis and chemical reactions. It is a derivative of pyridinecarboxylic acid and is commonly used as an intermediate in pharmaceutical and agrochemical manufacturing. 4-PYRIDINECARBOXYLIC ACID, 2-(BROMOMETHYL)-, METHYL ESTER is also utilized in the production of other organic compounds with diverse applications. It is important to handle this chemical with care as it can be hazardous if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 914639-05-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,4,6,3 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 914639-05:
(8*9)+(7*1)+(6*4)+(5*6)+(4*3)+(3*9)+(2*0)+(1*5)=177
177 % 10 = 7
So 914639-05-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H8BrNO2/c1-12-8(11)6-2-3-10-7(4-6)5-9/h2-4H,5H2,1H3
914639-05-7Relevant articles and documents
Five-membered or six-membered heterocyclic pyrimidine compound and applications thereof
-
, (2020/05/08)
The invention relates to a five-membered or six-membered heterocyclic pyrimidine compound for treating diseases responsive to activation of a TLR7 receptor, and a pharmaceutical composition.
AROMATIC ALDEHYDES WITH SUSTAINED AND ENHANCED IN VITRO AND IN VIVO PHARMACOLOGIC ACTIVITY TO TREAT SICKLE CELL DISEASE
-
, (2019/10/15)
Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are based on vanillin which is chemically modified to increase bioavailability and activity, e.g. so that the compounds bind to the F helix of hemoglobin (Hb) and prevent adhesion of red blood cells (RBCs).
ANTIVIRAL COMPOUNDS AND USE THEREOF
-
Page/Page column 29, (2009/12/02)
The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.
